机制研究:调节毒性因子,降低了Helicobacter pylori的粘附能力和炎症损伤
Chun Qin1,2, Gan-Rong Huang1,3, Ai-Xing Guan1,2
1Guangxi Technology Innovation Cooperation Base of Prevention and Control Pathogenic Microbes with Drug Resistance, Youjiang Medical University for Nationalities, Baise 533000, Guangxi Zhuang Autonomous Region, China.
World journal of gastroenterology
|January 31, 2024
概括
治疗通过降低CagA和VacA等关键因素来减弱Helicobacter pylori的毒性. 这减少了细菌粘附和胃炎症,为管理H. pylori感染提供了潜在的策略.
科学领域:
- 微生物学 微生物学
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
背景情况:
- 杆菌的致病性受到环境因素的影响,的作用尚不清楚.
- 了解对H.pylori毒性的影响对于开发新的治疗策略至关重要.
研究的目的:
- 为了研究对H.pylori毒性因子的影响.
- 为了确定如何降低H. pylori毒性因子的毒性.
主要方法:
- 杆菌菌株被用化治疗.
- 定量PCR和西式涂抹评估了CagA和VacA的表达.
- 转录学分析了毒性基因 (CagA,CagM,CagE,Cag1,Cag3,CagT) 的情况.
- 在小鼠模型中评估了H. pylori的殖民,炎症和细胞粘附.
主要成果:
- 化最初在H.pylori中的CagA和VacA表达上调,然后下调.
- 在治疗10天后,CagA和VacA的显著和持续下调发生.
- 转录组分析显示了多个H. pylori毒性因子的变化,CagM和CagE显示持续下调.
- 在小鼠中,用烯酸盐治疗的H. pylori表现出细胞粘附性减弱和胃炎症减少,尽管殖民性增加.
结论:
- 在10天后,H. pylori病毒性被化治疗减弱.
- 低毒性化合物化,有效地降低了H. pylori的细胞粘附.
- 这种机制减轻了胃粘膜的炎症损伤,表明了治疗潜力.
相关概念视频
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
592
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
592
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
407
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
407
01:24Adherens Junctions
4.8K
Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types – adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
Adherens Junctions are Dynamic
4.8K
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
430
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
430
01:28Peptic Ulcer Disease II: Pathophysiology
427
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
427
01:17Gastritis-II: Pathophysiology
327
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
327